drugset / Trial / NCT01879020
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of TA-8995 after multiple doses in healthy adult male subjects
Timeline
- Start
- 2009-08
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Obicetrapib | Small molecule | 1 mg | — |
| Subject | Obicetrapib | Small molecule | 2.5 mg | — |
| Subject | Obicetrapib | Small molecule | 5 mg | — |
| Subject | Obicetrapib | Small molecule | 10 mg | — |
| Subject | Obicetrapib | Small molecule | 25 mg | — |